Presentation is loading. Please wait.

Presentation is loading. Please wait.

Weng TC, et al. J Clin Pharm Ther 2010;35:139-51.

Similar presentations


Presentation on theme: "Weng TC, et al. J Clin Pharm Ther 2010;35:139-51."— Presentation transcript:

1 Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

2 Baseline characteristics of statin studies with paired-comparisons Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

3 Comparisons of the lipid lowering effect of different statins: LDL Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

4 Comparisons of the lipid lowering effect of different statins: HDL Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

5 Comparisons of the lipid lowering effect of different statins: TG Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

6 Low density lipoprotein (LDL) reduction (%) of different statins in different doses Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

7 Weighted mean difference (WMD) with 95% confidence interval (CI) of different statins at equivalent dose Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

8 Effects on cardiovascular events Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

9 Incidence of specific adverse effects (%) Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

10 Flow chart of the article selection Weng TC, et al. J Clin Pharm Ther 2010;35:139-51


Download ppt "Weng TC, et al. J Clin Pharm Ther 2010;35:139-51."

Similar presentations


Ads by Google